Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis.

Item

http://www.wikidata.org/entity/Q35915343

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis.

@ast

Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis.

@en

type

Item

label

Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis.

@ast

Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis.

@en

prefLabel

Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis.

@ast

Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis.

@en

P1476

Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis.

@en

P2093

Binghao Li

http://www.w3.org/2001/XMLSchema#string

Junbo Liang

http://www.w3.org/2001/XMLSchema#string

Li Yuan

http://www.w3.org/2001/XMLSchema#string

Zhaoming Ye

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.

Practical methods for incorporating summary time-to-event data into meta-analysis

Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial

Investigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children's Oncology Group.

Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma.

Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response?

Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model.

Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology Group.

Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation.

Targeting insulin-like growth factor 1 receptor in sarcomas.

P304

1949-1955

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S88293

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280867750

http://www.w3.org/2001/XMLSchema#string

P698

26251617

http://www.w3.org/2001/XMLSchema#string

P932

4524581

http://www.w3.org/2001/XMLSchema#string